ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Nephrology Prescribers in South Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SANJAY KUMAR MD

Nephrology

29,993

$2.31M

682
461 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$77
Average prescription price

Avg: $115

CHARLES MURDOCK MD

Nephrology

12,208

$937K

782
475 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 28%

$77
Average prescription price

Avg: $115

INDERPAL SINGH MD

Nephrology

10,839

$1.13M

688
372 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$105
Average prescription price

Avg: $115

MOUSTAFA MOUSTAFA M.D.

Nephrology

10,403

$1.06M

626
373 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 28%

$102
Average prescription price

Avg: $115

WILLIAM KENDRICK M.D.

Nephrology

9,146

$865K

359
186 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 28%

$95
Average prescription price

Avg: $115

JOHN PITTARD MD

Nephrology

8,605

$671K

484
204 are 65+

23%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $115

ALLAN TURNER M.D.

Nephrology

8,101

$1.69M

366
212 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 28%

$208
Average prescription price

Avg: $115

PUSADEE SUCHINDA MD

Nephrology

6,910

$929K

353
222 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 28%

$134
Average prescription price

Avg: $115

MUHAMMAD EBRAHIM MD

Nephrology

6,592

$457K

548
325 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $115

JOACHIM HERTEL MD

Nephrology

5,509

$837K

340
175 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 28%

$152
Average prescription price

Avg: $115

OSEMWEGIE EMOVON M.D.

Nephrology

5,385

$586K

250
127 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$109
Average prescription price

Avg: $115

VENUGOPAL GOVINDAPPA MD

Nephrology

5,281

$627K

555
280 are 65+

16%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$119
Average prescription price

Avg: $115

FREDERICK ROGOFF MD

Nephrology

5,134

$675K

342
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 28%

$132
Average prescription price

Avg: $115

LAWRENCE MCGEE MD

Nephrology

5,104

$410K

372
213 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$80
Average prescription price

Avg: $115

SIVANTHAN BALACHANDRAN MD

Nephrology

4,635

$1.21M

298
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 28%

$262
Average prescription price

Avg: $115

RALPH HENRY MD

Nephrology

4,480

$504K

446
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 28%

$113
Average prescription price

Avg: $115

CHRISTOPHER PO MD

Nephrology

4,438

$290K

438
293 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 28%

$65
Average prescription price

Avg: $115

DOUGLAS STAHURA D.O.

Nephrology

4,425

$472K

314
169 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 28%

$107
Average prescription price

Avg: $115

JAMES CAIN MD

Nephrology

4,261

$640K

250
129 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 28%

$150
Average prescription price

Avg: $115

JEFFREY SMITH D.O.

Nephrology

3,984

$771K

324
187 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 28%

$193
Average prescription price

Avg: $115

ZIA DIN MD

Nephrology

3,553

$334K

425
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$94
Average prescription price

Avg: $115

FRANCIS DIBONA M.D.

Nephrology

3,398

$506K

287
169 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 28%

$149
Average prescription price

Avg: $115

MATTHEW LAMBERT M.D.

Nephrology

3,340

$202K

467
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $115

REYNALDO MATUTE M.D.

Nephrology

3,252

$183K

163
102 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $115

CHARLES COHN M.D.

Nephrology

3,229

$402K

228
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 28%

$125
Average prescription price

Avg: $115

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank